Skip to main content
MOHMolina Healthcare IncSell3.9·$198.94-0.67%
Open full analysis

Molina Healthcare Inc (MOH) Stock Analysis

Breakout setup

SellHigh Confidence

Healthcare · Healthcare Plans

Sell if holding. Engine safety override at $198.94: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 3.9/10. Specifically: Below-average business quality.

Molina Healthcare provides managed care under Medicaid (75% of 2025 premium revenue, 4.57M members), Medicare, and Marketplace segments across 21 US states, serving approximately 5.5 million members total. Premium revenue was $43.1B in 2025 with an MCR of 91.7%; top four... Read more

$198.94+1.0% A.UpsideScore 3.9/10#11 of 11 Healthcare Plans
QualityF-score4 / 9FCF yield7.26%
Stop $184.98Target $200.85(resistance)A.R:R -1.1:1
Analyst target$190.25-4.4%16 analysts
$200.85our TP
$198.94price
$190.25mean
$129
$262

Sell if holding. Engine safety override at $198.94: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 3.9/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 68, MACD bullish. Score 3.9/10, high confidence.

Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity 37d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 22, 202637d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Product: Medicaid program (75.0%)
Target reached (-13.9% upside)
Quality below floor (3.0 < 4.0)

Key Metrics

P/E (TTM)53.7
P/E (Fwd)21.6
Mkt Cap$10.4B
EV/EBITDA8.1
Profit Mgn0.4%
ROE4.5%
Rev Growth-4.3%
Beta0.80
DividendNone
Rating analysts24

Quality Signals

Piotroski F4/9

Options Flow

P/C1.15bearish
IV70%elevated
Max Pain$390+96.0% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHProductMedicaid program75%
    10-K Item 1: 'Our Medicaid premium revenue constituted 75% of our consolidated premium revenue in the year ended December 31, 2025.'
  • MEDIUMGeographictop four Medicaid states (CA, NY, TX, WA)54%
    10-K Item 1A: 'top four health plans were in California, New York, Texas, and Washington, with aggregate Medicaid premium revenue of $17.3 billion, or approximately 54% of total Medicaid premium revenue'
  • LOWGeographicTexas Medicaid18%
    10-K Item 1: 'Our Texas Medicaid contracts represented approximately $5,735 million, or 18%, of consolidated Medicaid premium revenue in 2025.'
  • LOWGeographicCalifornia Medicaid13%
    10-K Item 1: 'Our California Medicaid contracts represented premium revenue of approximately $4,170 million, or 13%, of our consolidated Medicaid premium revenue in 2025.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

5 floor-breakers

Revenue shrinking — -4.3% YoY. Growth thesis broken unless recovery story develops.static

Earnings Growth
0.0
Revenue Growth
1.4
Declining revenue: -4%

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
1.8
Support Resistance
1.9
52w Position
1.9
Gap
6.0

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Net Margin
0.2
Operating Margin
0.7
Roa
1.3
Roe
1.5
Moat
3.1
Piotroski F
4.4
Current Ratio
5.9
Fcf Quality
10.0
Excellent cash conversion: 403% FCF/NINo competitive moat

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Erm
5.0
Earnings Timing
5.0
News Activity
5.0
Earnings concerns: 1B/3M

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
0.0
Quality Rank
3.2
Value Rank
4.7
GatesA.R:R -1.1=NEGATIVEMomentum 5.0<5.5 (soft — BUY_NOW allowed but watch)Momentum 5.0>=4.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 37d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
68 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $172.71Resistance $204.95

Price Targets

$185
$201
A.Upside+1.0%
A.R:R-1.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-13.9% upside)
! Quality below floor (3.0 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-07-22 (37d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MOH stock a buy right now?

Sell if holding. Engine safety override at $198.94: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 3.9/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 68, MACD bullish. Prior stop was $184.98. Score 3.9/10, high confidence.

What is the MOH stock price target?

Take-profit target: $200.85 (+1.0% upside). Prior stop was $184.98. Stop-loss: $184.98.

What are the risks of investing in MOH?

Concentration risk — Product: Medicaid program (75.0%); Target reached (-13.9% upside); Quality below floor (3.0 < 4.0).

Is MOH overvalued or undervalued?

Molina Healthcare Inc trades at a P/E of 53.7 (forward 21.6). TrendMatrix value score: 5.3/10. Verdict: Sell.

What do analysts say about MOH?

24 analysts cover MOH with a consensus score of 3.4/5. Average price target: $190.

What does Molina Healthcare Inc do?Molina Healthcare provides managed care under Medicaid (75% of 2025 premium revenue, 4.57M members), Medicare, and...

Molina Healthcare provides managed care under Medicaid (75% of 2025 premium revenue, 4.57M members), Medicare, and Marketplace segments across 21 US states, serving approximately 5.5 million members total. Premium revenue was $43.1B in 2025 with an MCR of 91.7%; top four Medicaid states (California, New York, Texas, Washington) account for ~54% of Medicaid premium revenue.

Related stocks: ALHC (Alignment Healthcare, Inc.) · OSCR (Oscar Health, Inc.) · CI (The Cigna Group) · PGNY (Progyny, Inc.) · CLOV (Clover Health Investments, Corp)
Home Stocks MOH

Latest news

Latest News

Benzinga5d ago
Benzinga5d agoProduct
Benzinga11d agoAnalyst
Benzinga24d agoAnalyst
Benzinga32d ago
Benzinga35d agoAnalyst
Benzinga35d agoAnalyst
Benzinga35d agoAnalyst
Benzinga38d ago
Benzinga38d ago
Benzinga45d ago
Benzinga48d ago
Benzinga49d agoAnalyst
Benzinga49d agoAnalyst
Benzinga52d agoAnalyst
Benzinga53d ago
Benzinga53d ago
Benzinga53d agoEarnings
Benzinga54d agoEarnings
Benzinga54d agoEarnings
Loading more...